Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 1:04 pm Purchase |
2024-12-31 | 13G | Eton Pharmaceuticals, Inc. ETON |
EcoR1 Capital LLC | 1,981,003 7.700% |
583,334 (+41.74%) |
Filing History |
| 2024-12-09 4:04 pm Purchase |
2024-12-02 | 13G | Eton Pharmaceuticals, Inc. ETON |
EcoR1 Capital LLC | 1,397,669 5.400% |
1,397,669 (New Position) |
Filing History |
| 2024-09-12 4:05 pm Purchase |
2024-09-09 | 13G | Eton Pharmaceuticals, Inc. ETON |
Opaleye Management Inc. | 2,722,500 10.340% |
197,613 (+7.83%) |
Filing History |
| 2024-04-30 07:00 am Sale |
2024-04-26 | 13D | Eton Pharmaceuticals, Inc. ETON |
HARROW INC. HROW |
0 0.000% |
-1,982,000 (Position Closed) |
Filing History |
| 2024-02-09 4:05 pm Purchase |
2023-12-31 | 13G | Eton Pharmaceuticals, Inc. ETON |
Opaleye Management Inc. | 2,524,887 9.840% |
354,887 (+16.35%) |
Filing History |
| 2023-01-20 4:53 pm Sale |
2022-12-31 | 13G | Eton Pharmaceuticals, Inc. ETON |
Opaleye Management Inc. | 2,170,000 8.580% |
-215,000 (-9.01%) |
Filing History |
| 2022-01-28 4:05 pm Sale |
2021-04-12 | 13D | Eton Pharmaceuticals, Inc. ETON |
HARROW INC. HROW |
1,982,000 8.100% |
-1,518,000 (-43.37%) |
Filing History |
| 2022-01-24 4:05 pm Sale |
2021-12-31 | 13G | Eton Pharmaceuticals, Inc. ETON |
Opaleye Management Inc. | 2,385,000 9.690% |
-1,307,700 (-35.41%) |
Filing History |
| 2021-06-17 4:40 pm Purchase |
2020-12-31 | 13G | Eton Pharmaceuticals, Inc. ETON |
Opaleye Management Inc. | 3,692,700 15.070% |
52,700 (+1.45%) |
Filing History |
| 2021-02-16 5:02 pm Sale |
2021-02-04 | 13G | Eton Pharmaceuticals, Inc. ETON |
APPEL PETER A | 1,084,329 4.480% |
-165,000 (-13.21%) |
Filing History |